关注
Despoina Aslanoglou
标题
引用次数
引用次数
年份
Intrinsic and antipsychotic drug-induced metabolic dysfunction in schizophrenia
Z Freyberg, D Aslanoglou, R Shah, JS Ballon
Frontiers in neuroscience 11, 432, 2017
822017
New roles for dopamine D2 and D3 receptors in pancreatic beta cell insulin secretion
ZJ Farino, TJ Morgenstern, A Maffei, M Quick, AJ De Solis, ...
Molecular psychiatry 25 (9), 2070-2085, 2020
762020
Dopamine regulates pancreatic glucagon and insulin secretion via adrenergic and dopaminergic receptors
D Aslanoglou, S Bertera, M Sánchez-Soto, R Benjamin Free, J Lee, ...
Translational psychiatry 11 (1), 59, 2021
692021
Ribosome-associated vesicles: A dynamic subcompartment of the endoplasmic reticulum in secretory cells
SD Carter, CM Hampton, R Langlois, R Melero, ZJ Farino, MJ Calderon, ...
Science advances 6 (14), eaay9572, 2020
492020
Gq/11-dependent regulation of endosomal cAMP generation by parathyroid hormone class B GPCR
AD White, FG Jean-Alphonse, F Fang, KA Peña, S Liu, GM König, A Inoue, ...
Proceedings of the National Academy of Sciences 117 (13), 7455-7460, 2020
392020
Vesicular glutamate transporter modulates sex differences in dopamine neuron vulnerability to age‐related neurodegeneration
SA Buck, T Steinkellner, D Aslanoglou, M Villeneuve, SH Bhatte, ...
Aging cell 20 (5), e13365, 2021
292021
Dopamine D2 receptor signaling modulates pancreatic beta cell circadian rhythms
H Wei, RC Zapata, M Lopez-Valencia, D Aslanoglou, ZJ Farino, V Benner, ...
Psychoneuroendocrinology 113, 104551, 2020
282020
Distinct agonist regulation of muscarinic acetylcholine M2-M3 heteromers and their corresponding homomers
D Aslanoglou, E Alvarez-Curto, S Marsango, G Milligan
Journal of Biological Chemistry 290 (23), 14785-14796, 2015
122015
Dual pancreatic adrenergic and dopaminergic signaling as a therapeutic target of bromocriptine
D Aslanoglou, S Bertera, L Friggeri, M Sánchez-Soto, J Lee, X Xue, ...
Iscience 25 (8), 2022
62022
Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
D Aslanoglou, EW George, Z Freyberg
JoVE (Journal of Visualized Experiments), e57531, 2018
62018
Development of Melanocortin 4 receptor agonists by Exploiting animal-derived macrocyclic, disulfide-rich peptide scaffolds
E Muratspahić, D Aslanoglou, AM White, C Draxler, X Kozisek, Z Farooq, ...
ACS Pharmacology & Translational Science 6 (10), 1373-1381, 2023
22023
VGLUT modulates sex differences in dopamine neuron vulnerability to age-related neurodegeneration
SA Buck, T Steinkellner, D Aslanoglou, M Villeneuve, SH Bhatte, ...
bioRxiv, 2020.11. 11.379008, 2020
12020
Development of novel tools for dissection of central versus peripheral dopamine D2-like receptor signaling in dysglycemia
A Bonifazi, M Ellenberger, ZJ Farino, D Aslanoglou, R Rais, S Pereira, ...
Diabetes, db240175, 2024
2024
Dual pancreatic adrenergic and dopaminergic signalling as a therapeutic target of bromocriptine
D Aslanoglou, S Bertera, M Sanchez-Soto, B Free, R Lane, L Friggeri, ...
BRITISH JOURNAL OF PHARMACOLOGY 180 (4), 508-509, 2023
2023
1299-P: Novel Tools to Dissect the Metabolic Roles of Central and Peripheral Dopamine D2-Like Receptors
A Bonifazi, MP Ellenberger, Z Farino, R Rais, J Mantilla-Rivas, ...
Diabetes 71 (Supplement_1), 2022
2022
1472-P: Dual Pancreatic Adrenergic and Dopaminergic Signaling as a Therapeutic Mechanism for Treatment of Dysglycemia by Bromocriptine
D Aslanoglou, S Bertera, L Friggeri, MS Soto, J Lee, X Xue, R Logan, ...
Diabetes 71 (Supplement_1), 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–16